Want to see CVS full AI Analyst Report?
CVS Stock Chart & Stats
$77.30
-$0.04(-0.09%)
At close: 4:00 PM EST
$77.30
-$0.04(-0.09%)
Day’s Range― - ―
52-Week Range$58.50 - $108.67
Previous CloseN/A
Volume5.40M
Average Volume (3M)8.05M
Market Cap
$135.89B
Enterprise Value$158.57K
Total Cash (Recent Filing)$11.80B
Total Debt (Recent Filing)$78.34B
Price to Earnings (P/E)46.5
Beta0.50
Next Earnings
Aug 05, 2026EPS Estimate
1.83Next Dividend Ex-DateN/A
Dividend Yield3.41%
Share Statistics
EPS (TTM)2.31
Shares Outstanding1,275,927,200
10 Day Avg. Volume6,412,993
30 Day Avg. Volume8,046,805
Financial Highlights & Ratios
PEG Ratio-0.92
Price to Book (P/B)1.34
Price to Sales (P/S)0.25
P/FCF Ratio12.88
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$110.13Price Target Upside42.46% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering17
EPS Forecast (FY)7.43
Revenue Forecast (FY)$408.35B
Bulls Say, Bears Say
Bulls Say
Strong Cash GenerationConsistent multi-billion operating and free cash flow provides durable financial flexibility to fund healthcare investments, pay dividends, de-lever, and support strategic initiatives (Health100, care delivery). That cash buffer underpins capital allocation over the next 2–6 months and beyond.
Vertical IntegrationOwning insurance (Aetna), PBM (Caremark) and retail/mail pharmacy creates structural synergies: retention, steerage to owned channels, and coordinated care programs. This durable model supports volume capture, margin management, and cross-segment cost control over multiple quarters.
Aetna Margin RecoveryMaterial improvement at Aetna—substantial AOI gain and a lower medical benefit ratio—signals sustainable underwriting progress. If maintained, restored insurance margins will materially lift enterprise operating income and help rebuild ROE and cash generation over the medium term.
Bears Say
Compressed ProfitabilitySharply lower margins and ROE vs prior years reflect structural pressure on pricing and costs. Persistently compressed profitability reduces earnings power, limits reinvestment capacity, and weakens the balance sheet's ability to generate returns across business cycles over coming quarters.
PBM Margin HeadwindsRebate guarantees and sustained pharmacy-client price concessions create ongoing downward pressure on PBM spread economics. Given PBM scale at CVS, persistent margin erosion or timing-driven volatility would structurally depress segment AOI and reduce predictable cash flow.
Regulatory / State UncertaintyFragmented state-level rules and evolving federal policy can materially alter pharmacy reimbursement, PBM contracting and access. Regulatory drift increases compliance costs, legal risk, and the chance of economically adverse rules that can persistently impair retail and PBM economics.
CVS Health News
CVS FAQ
What was CVS Health Corp’s price range in the past 12 months?
CVS Health Corp lowest stock price was $58.50 and its highest was $108.67 in the past 12 months.
What is CVS Health Corp’s market cap?
CVS Health Corp’s market cap is $135.89B.
When is CVS Health Corp’s upcoming earnings report date?
CVS Health Corp’s upcoming earnings report date is Aug 05, 2026 which is in 17 days.
How were CVS Health Corp’s earnings last quarter?
CVS Health Corp released its earnings results on May 06, 2026. The company reported $2.57 earnings per share for the quarter, beating the consensus estimate of $2.184 by $0.386.
Is CVS Health Corp overvalued?
According to Wall Street analysts CVS Health Corp’s price is currently Undervalued.
Does CVS Health Corp pay dividends?
CVS Health Corp pays a Quarterly dividend of $0.665 which represents an annual dividend yield of 3.41%. See more information on CVS Health Corp dividends here
What is CVS Health Corp’s EPS estimate?
CVS Health Corp’s EPS estimate is 1.83.
How many shares outstanding does CVS Health Corp have?
CVS Health Corp has 1,275,927,200 shares outstanding.
What happened to CVS Health Corp’s price movement after its last earnings report?
CVS Health Corp reported an EPS of $2.57 in its last earnings report, beating expectations of $2.184. Following the earnings report the stock price went up 7.647%.
Which hedge fund is a major shareholder of CVS Health Corp?
Currently, no hedge funds are holding shares in CVS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
CVS Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$110.13 (42.46% Upside)
$110.13 (42.46% Upside)
Blogger Sentiment
Bullish
CVS Sentiment 70%
Sector Average 66%
Sector Average 66%
Hedge Fund Trend
Decreased
By 18.9M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $323.7M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 0.3%
Last 30 Days ▲ 1.6%
Last 30 Days ▲ 1.6%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
75.98%
12-Months-Change
Fundamentals
Return on Equity
3.87%
Trailing 12-Months
Asset Growth
-1.02%
Trailing 12-Months
Company Description
CVS Health Corp
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
CVS Revenue Breakdown
46.57% Health Services
35.05% Health Care Benefits
33.40% Pharmacy & Consumer Wellness
0.12% Corporate/ Other
CVS Stock 12 Month Forecast
Average Price Target
$110.13
▲(42.46% Upside)
Technical Analysis
Ownership Overview
0.41% Insiders
32.79% Mutual Funds
0.57% Other Institutional Investors
44.77% Public Companies and Individual Investors